|Articles|June 28, 2016
inVentiv Health Selected By Pfizer as Preferred Provider
inVentiv Health Inc. announced that it has been selected by Pfizer Inc. as one of its preferred partners in the delivery of clinical operations services.
Advertisement
inVentiv Health Inc. announced that it has been selected by Pfizer Inc. as one of its preferred partners in the delivery of clinical operations services. inVentiv Health will assist in Pfizer's sourcing strategy for global clinical operations services. Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
eClinical Technology: Misconceptions, Challenges, and OpportunitiesSeptember 9th 2025
How Sponsors Can Modernize Tools to Support PhysiciansSeptember 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
2
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
3
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
4
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
